Literature DB >> 24091615

Timeliness of care and prognosis in patients with lung cancer.

F J Gonzalez-Barcala1, J A Falagan, J M Garcia-Prim, L Valdes, J M Carreira, A Puga, P Martín-Lancharro, M T Garcia-Sanz, D Anton-Sanmartin, J C Canive-Gomez, A Pose-Reino, R Lopez-Lopez.   

Abstract

BACKGROUND: Timeliness of care is an important dimension of health care quality. The determining factors of less timely care and their influence on the survival of patients with lung cancer (LC) remain uncertain. AIMS: To analyse the delays in the diagnosis and treatment of LC in our health area, the factors associated with the timeliness of care and their possible relationship with the survival of these patients.
METHODS: A retrospective study was conducted on all patients with a cytohistologically confirmed diagnosis of LC between 1 June 2005 and 31 May 2008. The time delays for consultation (specialist delay), diagnosis (diagnosis delay), and treatment (treatment delay), were analysed, as well as the factors associated with these delays and the influence of the timeliness of care on survival.
RESULTS: A total of 307 cases were included (87 % males). The mean specialist delay was 53.6 days (median 35 days), diagnosis delay 31.5 days (median 18 days), treatment delay 23.5 days (median 14 days). The greater age of the patient and a more advanced stage were associated with a shorter specialist delay. Male sex, a more advanced stage, and poor general status were associated with a shorter treatment delay. The survival is longer in patients with a longer treatment delay.
CONCLUSIONS: The delay in the diagnosis in our population seems to be excessively long. The greater the age, a more advanced tumour stage, male sex, and poor general health status are associated with shorter delays. A longer treatment delay is associated with a longer survival.

Entities:  

Mesh:

Year:  2013        PMID: 24091615     DOI: 10.1007/s11845-013-1025-8

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  35 in total

1.  Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis.

Authors:  Dorothy S Lo; Robert A Zeldin; Roland Skrastins; Ian M Fraser; Harold Newman; Alan Monavvari; Yee C Ung; Harry Joseph; Teresa Downton; Larissa Maxwell; Jacinta Meharchand
Journal:  J Thorac Oncol       Date:  2007-11       Impact factor: 15.609

2.  Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanning.

Authors:  Pepijn Brocken; Berni A B Kiers; Monika G Looijen-Salamon; P N Richard Dekhuijzen; Chantal Smits-van der Graaf; Liesbeth Peters-Bax; Lioe-Fee de Geus-Oei; Henricus F M van der Heijden
Journal:  Lung Cancer       Date:  2011-09-22       Impact factor: 5.705

3.  Treatment delays in non-small cell lung cancer and their prognostic implications.

Authors:  Razvan Diaconescu; Chantal Lafond; Renaud Whittom
Journal:  J Thorac Oncol       Date:  2011-07       Impact factor: 15.609

4.  The impact of delayed diagnosis of lung cancer on the stage at the time of operation.

Authors:  E D Christensen; T Harvald; M Jendresen; S Aggestrup; G Petterson
Journal:  Eur J Cardiothorac Surg       Date:  1997-12       Impact factor: 4.191

5.  Delays in the diagnosis and surgical treatment of lung cancer.

Authors:  J S Billing; F C Wells
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

6.  Delays in the diagnostic pathways for primary pulmonary carcinoma in Southern Norway.

Authors:  Heidi B Rolke; Per S Bakke; Frode Gallefoss
Journal:  Respir Med       Date:  2006-12-05       Impact factor: 3.415

7.  Delays in the diagnosis and treatment of lung cancer.

Authors:  Eija-Riitta Salomaa; Susanna Sällinen; Heikki Hiekkanen; Kari Liippo
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

8.  Lung cancer: clinical presentation and specialist referral time.

Authors:  G Buccheri; D Ferrigno
Journal:  Eur Respir J       Date:  2004-12       Impact factor: 16.671

9.  Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?

Authors:  Jeffrey T Yorio; Yang Xie; Jingsheng Yan; David E Gerber
Journal:  J Thorac Oncol       Date:  2009-11       Impact factor: 15.609

10.  The impact of timeliness of care on survival in non-small cell lung cancer patients.

Authors:  Elżbieta Radzikowska; Kazimierz Roszkowski-Śliż; Piotr Głaz
Journal:  Pneumonol Alergol Pol       Date:  2012
View more
  6 in total

1.  Lung cancer care trajectory at a Canadian centre: an evaluation of how wait times affect clinical outcomes.

Authors:  G Kasymjanova; D Small; V Cohen; R T Jagoe; G Batist; W Sateren; P Ernst; C Pepe; L Sakr; J Agulnik
Journal:  Curr Oncol       Date:  2017-10-25       Impact factor: 3.677

2.  Timeliness of Care and Lung Cancer Tumor-Stage Progression: How Long Can We Wait?

Authors:  Amelia W Maiga; Stephen A Deppen; Rhonda Pinkerman; Carol Callaway-Lane; Pierre P Massion; Robert S Dittus; Eric S Lambright; Jonathan C Nesbitt; David Baker; Eric L Grogan
Journal:  Ann Thorac Surg       Date:  2017-10-21       Impact factor: 4.330

3.  Impact of Timeliness of Surgical Treatment on the Outcomes of Patients with Non-metastatic Non-small Cell Lung Cancer: Findings From the PLCO Trial.

Authors:  Omar Abdel-Rahman
Journal:  World J Surg       Date:  2019-11       Impact factor: 3.352

Review 4.  Defining timeliness in care for patients with lung cancer: a scoping review.

Authors:  Adnan Ansar; Virginia Lewis; Christine Faye McDonald; Chaojie Liu; Muhammad Aziz Rahman
Journal:  BMJ Open       Date:  2022-04-07       Impact factor: 2.692

5.  The Use of Bronchoscopy During the Coronavirus Disease 2019 Pandemic: CHEST/AABIP Guideline and Expert Panel Report.

Authors:  Momen M Wahidi; Samira Shojaee; Carla R Lamb; David Ost; Fabien Maldonado; George Eapen; Daniel A Caroff; Michael P Stevens; Daniel R Ouellette; Craig Lilly; Donna D Gardner; Kristen Glisinski; Kelly Pennington; Raed Alalawi
Journal:  Chest       Date:  2020-05-01       Impact factor: 9.410

6.  Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review.

Authors:  Helen Hall; Adam Tocock; Sarah Burdett; David Fisher; William M Ricketts; John Robson; Thomas Round; Sarita Gorolay; Emma MacArthur; Donna Chung; Sam M Janes; Michael D Peake; Neal Navani
Journal:  Thorax       Date:  2021-08-17       Impact factor: 9.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.